Results of a preliminary study using hypofractionated involved-field radiation therapy and concurrent carboplatin/paclitaxel in the treatment of locally advanced non-small-cell lung cancer

International Journal of Clinical Oncology

Volumn 14, Issue 5, 2009, Pages 408-415

  Matsuura, Kanji ^a   Kimura, Tomoki ^b   Kashiwado, Kozo ^a   Fujita, Kazushi ^c   Akagi, Yukio ^d   Yuki, Shintarou ^e   Murakami, Yuji ^e   Wadasaki, Koichi ^f   Monzen, Yoshio ^f   Ito, Atsushi ^g   Kagemoto, Masayuki ^g   Mori, Masaki ^a   Ito, Katsuhide ^e   Nagata, Yasushi ^h  

^a ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c Saijo cho   (Japan)

^d HIROSHIMA CITY ASA HOSPITAL   (Japan)

^e HIROSHIMA UNIVERSITY   (Japan)

^f HIROSHIMA PREFECTURAL HOSPITAL   (Japan)

^g HIROSHIMA CITY HOSPITAL   (Japan)

^h HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Carboplatin (CBDCA); Elective nodal irradiation (ENI); Involved field radiation therapy (IFRT); Non small cell lung cancer (NSCLC); Paclitaxel (PTX); Three dimensional conformal radiation therapy (3DCRT)

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ANEMIA; AREA UNDER THE CURVE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATITIS; DRUG EFFICACY; DRUG FEVER; ESOPHAGITIS; FATIGUE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; NEUTROPENIA; OVERALL SURVIVAL; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEASIBILITY STUDIES; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PACLITAXEL; PILOT PROJECTS; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 70350493149     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-009-0889-0     Document Type: Article

References (25)

1. D.G. Pfister D.H. Johson C.G. Azzoli, et al. 2004 American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003 J Clin Oncol 22 330 353 10.1200/JCO.2004.09.053 14691125 (Pubitemid 41095099)
2. W.J. Curran C.B. Scott C.J. Langer, et al. 2003 Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemoradiation for patients with unresected stage III NSCLC: RTOG 9410 Proc Am Soc Clin Oncol 22 621
3. P. Zatloukal L. Petruzelka M. Zemanova, et al. 2004 Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small-cell lung cancer. A randomized study Lung Cancer 46 87 98 10.1016/j.lungcan.2004.03.004 15364136 (Pubitemid 39201387)
4. C.P. Belani H. Choy P. Bonomi, et al. 2005 Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol J Clin Oncol 23 5883 5891 10.1200/JCO.2005.55.405 1:CAS:528:DC%2BD2MXhtVKgtbzM 16087941 (Pubitemid 46300204)
5. F. Pierre R. Gilles T. Pascal, et al. 2005 Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study J Clin Oncol 25 5910 5917
6. M. Saunders S. Dische A. Barrett, et al. 1999 Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from a randomised multicentre trial Radiother Oncol 52 137 148 10.1016/S0167-8140(99)00087-0 1:STN:280:DC%2BD3c%2FktlKnug%3D%3D 10577699 (Pubitemid 29461081)
7. C. Schaake-Koning W. van den Bogaert O. Dalesio, et al. 1992 Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer N Engl J Med 326 524 530 1:STN:280:DyaK387itleisg%3D%3D 1310160
8. S. Senan S. Burgers M.J. Samson, et al. 2002 Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy Int J Radiat Oncol Biol Phys 54 999 1006 10.1016/S0360-3016(02) 03028-6 12419425 (Pubitemid 35299439)
9. K.E. Rosenzweig S.E. Sim B. Mychalczak, et al. 2001 Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy Int J Radiat Oncol Biol Phys 50 681 685 1:STN:280:DC%2BD3MzislyjtQ%3D%3D 11395236
10. T. Kimura Y. Hirokawa Y. Murakami, et al. 2004 The preliminary results of accelerated hyperfractionated radiotherapy with involved-field omitted elective nodal irradiation (ENI) for inoperable advanced non-small cell lung cancer (in Japanese with English abstract) J Jpn Soc Ther Radiol Oncol 16 79 84
11. M.V. Graham J.A. Purdy B. Emami, et al. 1999 Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys 45 323 329 1:STN:280: DyaK1MvhsFCqsQ%3D%3D 10487552
12. K. Tsujino S. Hirota M. Endo, et al. 2003 Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer Int J Radiat Oncol Biol Phys 55 110 115 10.1016/S0360-3016(02)03807-5 12504042 (Pubitemid 36020349)
13. J.D. Bradley M.V. Graham K.W. Winter, et al. 2003 Acute and late toxicity results of RTOG 9311: a dose escalation study using 3D conformal radiation therapy in patients with inoperable non-small cell lung cancer Int J Radiat Oncol Biol Phys 57 137 138
14. N. Ohashi K. Arita H. Daga, et al. 2003 Sequential phase I studies of paclitaxel +/- carboplatin and hyperfractionated radiation therapy (HFX RT) for advanced non-small cell lung cancer (NSCLC) Proc Am Soc Clin Oncol 22 680
15. M. Uematsu A. Shioda A. Suda, et al. 2001 Computed tomography-guided frameless stereotactic radiotherapy for stage I nonsmall cell lung cancer: a 5-year experience Int J Radiat Oncol Biol Phys 51 666 670 1:STN:280: DC%2BD3MrltFGisA%3D%3D 11597807
16. H. Onishi T. Araki H. Shirato, et al. 2004 Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study Cancer 101 1623 1631 10.1002/cncr.20539 15378503 (Pubitemid 39318910)
17. Y. Nagata K. Takayama Y. Matsuo, et al. 2005 Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in four fractions for primary lung cancer using a stereotactic body frame Int J Radiat Oncol Biol Phys 63 1427 1431 10.1016/j.ijrobp.2005.05.034 16169670 (Pubitemid 41628038)
18. Chang JY, Bradley JD, Govindan R, et al. (2008) Thoracic tumors. In: Halperin EC, Perez CA, Brady LW (eds) Perez and Brady's principles and practice of radiation oncology, 5th edn. Lippincott Williams & Wilkins, Philadelphia, PA, pp 1076-1108
19. K.E. Rosenzweig S. Sura A. Jackson, et al. 2007 Involved-field radiation therapy for inoperable non-small-cell lung cancer J Clin Oncol 35 5557 5561 10.1200/JCO.2007.13.2191
20. S. Yuan X. Sun M. Li, et al. 2007 A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer Am J Clin Oncol 30 239 244 10.1097/01.coc.0000256691.27796.24 1:CAS:528:DC%2BD2sXnvVGiurw%3D 17551299 (Pubitemid 46884142)
21. J.D. Bradley M.V. Graham K. Winter, et al. 2005 Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma Int J Radiat Oncol Biol Phys 61 318 328 15667949
22. J.D. Bradley M. Graham S. Suzanne, et al. 2005 Phase I results of RTOG L-0117; a phase I/II dose intensification study using 3DCRT and concurrent chemotherapy for patients with Inoperable NSCLC J Clin Oncol 23 636 10.1200/JCO.2005.12.120 (Pubitemid 46243491)
23. S.E. Schild W.L. McGinnis D. Graham, et al. 2006 Results of a phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer Int J Radiat Oncol Biol Phys 15 1106 1111
24. M.A. Socinski A.W. Blackstock J.A. Bogart, et al. 2008 Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105 J Clin Oncol 26 2457 2463 10.1200/JCO.2007.14.7371 1:CAS:528:DC%2BD1cXnsVKhur4%3D 18487565
25. A.W. Blackstock R. Govindan 2007 Definitive chemoradiation for the treatment of locally advanced non-small-cell lung cancer J Clin Oncol 25 4146 4152 10.1200/JCO.2007.12.6581 1:CAS:528:DC%2BD2sXhtlKqsbvM 17827465 (Pubitemid 47492959)